EFFECT OF UPADACITINIB ON EXTRAINTESTINAL MANIFESTATIONS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE
Jean-Frédéric Colombel 1
David P. Hudesman 2
Qian Cao 3
Subrata Ghosh 4
Walter Reinisch 5
Ana Paula Machado De Lacerda 6
Elena Dubcenco 6
Chirag Doshi 6
Samuel Anyanwu 6
Tian Feng 6
1 Icahn School of Medicine at Mount Sinai, New York, United States
2 NYU Langone Health, New York, NY, United States
3 Sin Run Shaw Hospital, College of Medicine Zhejiang University, Hanzhou, China
4 University College Cork, Cork, Ireland
5 Medical University of Vienna, Vienna, Austria
6 AbbVie Inc., North Chicago, United States
Topic
IBD
Conference
UEG Week Copenhagen 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]